PRESS RELEASE published on 08/13/2026 at 23:20, 28 days 12 hours ago DeFi Technologies Inc. Announces Second Quarter 2026 Financial Results with Revenue of $7.8 Million, Operating Loss of $2.3 Million, and Maintained Strong Balance Sheet DeFi Technologies Inc. announces Q2 2026 financial results with $7.8M revenue and $2.3M operating loss. Strong balance sheet with $135M in assets. Continued growth in platform monetization and strategic capital deployment Financial Results Revenue Balance Sheet Operating Loss DeFi Technologies Inc.
PRESS RELEASE published on 08/13/2026 at 23:16, 28 days 12 hours ago Ranchbot Raises Over US$15 Million to Invest in the Future of American Ranching FORT WORTH, Texas, USA, August 13th, 2026, FinanceWire
PRESS RELEASE published on 08/13/2026 at 23:00, 28 days 13 hours ago Why Are Four of Washington's Most Senior Defense Officials All Working for the Same Nasdaq Company? WSW, NY, August 13th, 2026, FinanceWire
PRESS RELEASE published on 08/13/2026 at 22:56, 28 days 13 hours ago BIRKENSTOCK ANNOUNCES LAUNCH OF SECONDARY OFFERING AND CONCURRENT SHARE REPURCHASE Birkenstock Holding plc announces launch of secondary offering & concurrent share repurchase by affiliated entity, L Catterton, with underwriter J.P. Morgan. No proceeds to BIRKENSTOCK from sales. Cautionary statement regarding forward-looking statements provided Share Repurchase BIRKENSTOCK Secondary Offering Underwriter Cautionary Statement
PRESS RELEASE published on 08/13/2026 at 22:38, 28 days 13 hours ago Predictiv AI Announces Debt Settlement and Provides Additional Details of Previously Announced Consulting Agreement With Aktien Media Inc. Predictiv AI Inc. settles $298,272 debt through issuing common shares. Company engages Aktien Media Inc. for internet advertising services targeting European investors. Forward-looking statements included Debt Settlement Forward-looking Statements Predictiv AI Inc. Internet Advertising Aktien Media Inc.
PRESS RELEASE published on 08/13/2026 at 22:00, 28 days 14 hours ago Inside Information / Operations of the issuer (acquisitions, sales...) Innate Pharma announces proposed offering of ordinary shares worth approximately t €22.5 million, anchored by global coordinator Stifel, for continued clinical development and corporate purposes Ordinary Shares Clinical Development Offering Innate Pharma Stifel
PRESS RELEASE published on 08/13/2026 at 22:00, 28 days 14 hours ago Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...) Innate Pharma annonce un projet d'émission d'actions ordinaires pour financer le développement clinique et les besoins généraux de l'entreprise. Stifel et BTIG agissent en tant que coordinateur global et teneurs de livre conjoints Développement Clinique Actions Ordinaires Innate Pharma Stifel BTIG
PRESS RELEASE published on 08/13/2026 at 20:04, 28 days 16 hours ago Neel Khokhani's Epochal Corporation Opens Monaco Office, Adding a European Base Alongside Dubai Dubai, United Arab Emirates, August 13th, 2026, FinanceWire
PRESS RELEASE published on 08/13/2026 at 20:03, 28 days 16 hours ago Evebot Smart: Upgrade Food Printing with Visual Positioning Tsim Sha Tsui, Hong Kong, China, August 13th, 2026, FinanceWire
PRESS RELEASE published on 08/13/2026 at 20:00, 28 days 16 hours ago Mise à disposition des documents préparatoires à l'Assemblée Générale Mixte du 17 septembre 2026 Communiqué présentant la mise à disposition des documents préparatoires à l'Assemblée Générale Mixte du 17 septembre 2026 de Poujoulat SA Actionnaires Convocation Consultation Documents Préparatoires Assemblée Générale Mixte
Published on 09/11/2026 at 04:00, 8 hours 14 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 13 hours 49 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 20 hours 54 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 21 hours 14 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 11:43, 31 minutes ago Skyborn reaches Financial Close on the Gennaker offshore wind farm project
Published on 09/11/2026 at 11:35, 39 minutes ago EQS-Adhoc: Correction of a release from 10/09/2026, 19:35 CET/CEST - United Internet AG: Group subsidiaries 1&1 AG and IONOS Group SE launch transformation programs
Published on 09/11/2026 at 11:30, 44 minutes ago Galimedix Therapeutics to present functional feasibility data from Phase 2 eDREAM study in geographic atrophy at 26th EURETINA Congress
Published on 09/11/2026 at 10:15, 1 hour 59 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 07:00, 5 hours 14 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 5 hours 14 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 5 hours 14 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 16 hours 44 minutes ago Availability of the 2026 Interim Financial Report